Welcome to our dedicated page for Cue Health news (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Cue Health stock.
Cue Health Inc. news covered the company's healthcare technology business, including diagnostic-enabled care, at-home and point-of-care molecular testing, telehealth services, FDA-related product developments, earnings releases, and governance actions. Recurring updates described its COVID-19 and Mpox diagnostic products, customer categories across public agencies and private-sector healthcare users, and cost-reduction or operational efficiency actions.
Later Cue Health news documented the company's Chapter 7 bankruptcy filing and planned wind down, including the intended sale of assets and creditor-payment process under the Bankruptcy Code.
Cue Health has filed a registration statement on Form S-1 with the SEC for a proposed initial public offering (IPO) of its common stock, with details on the number of shares and price range yet to be determined. The company plans to list its stock on the Nasdaq under the ticker symbol HLTH. Goldman Sachs, Morgan Stanley, and Cowen will act as lead underwriters for the offering. A preliminary prospectus will be available once the statement becomes effective.